Dysport 500u 30-49 x vials

Description

Dysport® (abobotulinumtoxinA) by Galderma is a prescription-only botulinum toxin type A approved by the TGA for the temporary improvement of moderate to severe glabellar lines. The 500-unit vial is designed to support efficient treatment planning across multiple patients, with established diffusion and dosing characteristics. All treatments are provided following a medical consultation and under appropriate medical oversight, in line with Australian regulatory requirements. Dysport works by inhibiting acetylcholine release at the neuromuscular junction, reducing targeted muscle activity. This promotional offering is available to qualified nurses practising within their professional scope and supported by clinical governance and prescribing arrangements.